Applications of (S)-3-Amino-3-(4-Chloro-Phenyl)-Propionic Acid in Industrial Manufacturing

As a direct manufacturer, we supply (S)-3-Amino-3-(4-Chloro-Phenyl)-Propionic Acid to major industrial sectors requiring precise integration of chiral intermediates for high-value synthesis. Our production supports strict downstream demands in pharmaceuticals, agrochemicals, fine chemicals, and advanced material fields. Each industry segment requires strict adherence to specific compliance frameworks, optimized formulation ratios, and controlled process steps to achieve targeted end-use performance.

1. Chiral Pharmaceutical Intermediate for Antiepileptic Drugs

Leading pharmaceutical companies incorporate this compound as a critical chiral building block in the synthesis of several antiepileptic and neuroactive agents, especially derivatives related to (S)-enantiomeric structures. It integrates after the initial core aromatic construction, supporting the stereoselective extension of propionic acid motifs essential for specific API attributes. Precise enantiopurity and trace impurity control remain essential throughout the process to meet regulatory acceptance for human use.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• USP-NF and Ph. Eur. guidelines for chiral intermediates
• FDA 21 CFR Part 211 for finished pharmaceuticals
• EDQM CEP registration pathways

Typical usage ratio

• Employed at 0.8 to 1.3 molar equivalents in target synthesis; adjusted for downstream yield and chiral enrichment targets during process scale-up.

Downstream process integration

• Introduced after Grignard or Suzuki coupling steps for aromatic core extension, followed by amidation and cyclization under controlled pH. Chiral enrichment monitored by HPLC or SFC, adapted according to API pathway.

Final product types

• Levetiracetam and analog API intermediates
• Stereospecific nervous system drug candidates
• Enantiopure fine chemicals for CNS drug research
• Generic pharmaceutical substance intermediates

2. Precursor in Chiral Agrochemical Synthesis

Major agrochemical producers utilize this material to introduce chiral centers and fine-tune bioactivity in advanced herbicide and insecticide molecules. It supports the development of selective compounds with improved field performance and minimized off-target effects. Handling and formulation processes require strict control against racemization and byproduct formation in high-throughput batch reactors typical of agrochemical manufacturing.

Industry compliance standards

• FAO/WHO specifications for pesticide active ingredients
• REACH Regulation (EC 1907/2006) registration
• ISO 9001:2015 Quality Management for chemical manufacture
• OECD Test Guidelines for Analytical Chemistry

Typical usage ratio

• Applied at 5–12% w/w in final active ingredient synthesis cycles, optimized based on intended selectivity and required minimum impurity profile in field formulations.

Downstream process integration

• Fed post-aromatic chlorination phases into condensation or acylation reactions. Chiral intermediate formation monitored by in-process NMR and controlled for batch reproducibility and scalability per campaign.

Final product types

• Chiral herbicide actives
• Enantiopure insecticidal intermediates
• Specialty plant growth regulator scaffolds
• Patent-protected crop-protection compound precursors

3. Fine Chemical and Peptide Synthesis Building Block

Peptide manufacturers use this amino acid derivative as a specialized chiral monomer for creating custom polypeptides, bioactive oligopeptides, and complex research chemicals. It enters solid-phase synthesis protocols, where stability against racemization and side-chain protection strategies are required for accurate sequence assembly and post-synthetic modification. Critical for manufacturing designer peptide sequences with integrated aromatic-chlorine motifs.

Industry compliance standards

• ISO 13485:2016 for peptide synthesis in life science applications
• USP General Chapter <1047> for peptide drugs
• ISO 9001 for custom chemical manufacture
• European Pharmacopoeia General Monographs for peptides and amino acid derivatives

Typical usage ratio

• Used at 1 equivalent per target residue in custom peptides; adjusted per total sequence length, degree of substitution, and purification strategy.

Downstream process integration

• Introduced at the Fmoc-protected amino acid coupling step in SPPS, with specialized activators to maintain chirality and avoid side-product formation during chain elongation.

Final product types

• Research-scale designer peptides
• Bioactive peptide analogs
• Custom-modified oligopeptide building blocks
• Reference standards for peptide mapping

4. Intermediate for Pharmaceutical Impurity Profiling and Reference Standards

Analytical laboratories and quality control teams acquire this compound for the preparation of certified reference standards and analytical markers, particularly in quantitative impurity profiling for related drug substances. It ensures traceability and accurate calibration in HPLC, LC-MS, and NMR validation protocols. Laboratories demand batch-to-batch consistency and contaminant-free raw material to avoid analytical bias.

Industry compliance standards

• Ph. Eur. General Chapter 5.10 for reference standards
• USP <11> and ISO 17025 for analytical reference materials
• FDA Guidance on Analytical Procedures and Methods Validation
• ICH Q3A (R2) Guideline on Impurities in New Drug Substances

Typical usage ratio

• Weighed as neat substance, typically 1–50 mg per analytical batch, exact mass determined by calibration method requirements for limit of detection and quantification thresholds.

Downstream process integration

• Dissolved or diluted with reference-grade solvents, introduced into instrument calibration, method development, and positive control validation setups according to regulated laboratory workflows.

Final product types

• Pharmaceutical impurity reference standards
• Certified calibration standards for regulatory filings
• Working standards for drug substance QC
• Traceable analytical control samples for release testing